share_log

Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106

Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106

瑞穗維持對Axsome Therapeutics的買入,將目標股價下調至106美元
Benzinga ·  05/08 07:12

Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and lowers the price target from $109 to $106.

瑞穗分析師格雷格·蘇萬納維耶維持Axsome Therapeutics(納斯達克股票代碼:AXSM)的買入並將目標股價從109美元下調至106美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論